Login / Signup

Real-World Situation of Eradication Regimens and Risk Factors for Helicobacter pylori Treatment in China: A Retrospective Single-Center Study.

Jianping ChengChanjuan FanZhen LiZhaojing DongXiaolin ZhaoYong CaiHaiou DingYan DouXiaomei Zhang
Published in: Clinical and experimental gastroenterology (2024)
This study was registered in the Chinese Clinical Trial Registry on 08/01/2024 (clinical trial registration number: ChiCTR2400079647).
Keyphrases
  • helicobacter pylori
  • clinical trial
  • helicobacter pylori infection
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • combination therapy